Spherix Incorporated to Seek Stockholder Approval of Reverse Stock Split
... BETHESDA, Md., Sept. 8 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: spex ) announced that it will seek stockholder approval to implement a reverse stock split at a Special Meeting of Stockholders on November 17, 2008, in an...Market Research Shows Spherix's Naturlose(R) Readily Accepted by Diabetes Patients
...abroad, has been found to reduce the spikes of serum glucose that follow consumption of food (1). In a Phase 3 human clinical trial, Spherix (Nasdaq: spex ) is currently studying the efficacy and safety of Naturlose for the treatment of diabetes. While the Phase 3 trial is ongoing, Spherix has engaged ma...Spherix Reports First Quarter 2009 Earnings
... BETHESDA, Md., May 14 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: spex ), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnolo...Spherix Elects New Independent Director, and Elects Chairman of the Board
... BETHESDA, Md., May 14 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: spex ), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnolo...Spherix Postpones 2009 Annual Shareholders Meeting to Share Interim Diabetes Clinical Trial Data
...ROM PHASE 3 CLINICAL TRIAL FOR NATURLOSE(R) ANTICIPATED BY FALL BETHESDA, Md., March 11 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: spex ), an innovator in biotechnology and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical ...Patient Recruitment Begins in India for Phase 3 Diabetes Trial
... BETHESDA, Md., Nov. 7 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: spex ) reported that patient recruitment for its Phase 3 clinical trial of its potential type 2 diabetes drug, Naturlose(R), has begun in India. Expectatio...Spherix Expands Phase 3 Naturlose Diabetes Trial Outside of the U.S.
... BETHESDA, Md., July 14 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: spex ) reported that the Phase 3 clinical trial of its potential type 2 diabetes drug, Naturlose(R), will expand outside of the United States. Several coun...Spherix D-tagatose to be Supplied by Inalco SpA
... BETHESDA, Md., April 30 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: spex ) announced today that it has signed letters of intent with Inalco SpA, an Italy-based manufacturer of bulk pharmaceutical ingredients, to supply a po...Growth Achieved in Spherix's Health Sciences Consulting Business
... Phase 3 Clinical Trial on Track, Market Research Contracts Signed BELTSVILLE, Md., Nov. 29 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: spex ) has recently signed contracts to provide technical and regulatory consulting services to several major consumer, food, ingredient, and pharmaceutica...Spherix Reports Second Quarter Earnings
... Losses Primarily Due to Scheduled Start of Phase 3 Clinical Trial BELTSVILLE, Md., Aug. 14 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: spex ) has reported a second quarter 2007 loss from continuing operations of $1.9 million, or 13 cents per share, compared to a loss from continuing operat...SPEX SkinSkan Spectro-Fluorometer
Description:... The spex SkinSkan is the only in-vivo, fibre-optic spectrofluorometer designed specifically for skin-fluorescence measurements. It is also ideal for many remot...MaximEyes Optometric & Ophthalmology Software for Practice Management and Electronic Medical Records
Features:...m layouts, comprehensive referral letters, and MS Word integration. Reconcile frames inventory with the physical inventory count. Integrate with spex by Frames Data monthly CD and Frames Data quarterly CD. ...MaximEyes Practice Management and Electronic Medical Records Software Solutions
Features:...m layouts, comprehensive referral letters, and MS Word integration. Reconcile frames inventory with the physical inventory count. Integrate with spex by Frames Data monthly CD and Frames Data quarterly CD. ...Phosphorescence lifetime measured using the SPEX phosphorimeter
Introduction A phosphorimeter integral to the SPEX FLUOROMAX -P or as an accessory on the SPEX FLUOROLOG system can uncover important information on various systems of chemical and biochemical interest, by revealing data normally masked by intense but rapid ...Photoluminescence Spectroscopy of Quantum Dots, monitored by the Spex FluoroMax
The optical properties of quantum dots (QDs) have potential applications in optoelectronics, biosensing and biolabeling, memory devices, and sources of laser light. For example, alloyed CdSeTe QDs are shown herein to possess a nonlinear change i...Spherix Announces Termination of Arla License Agreement
...armaceutical and Health-Oriented Nutraceutical Uses of Naturlose BETHESDA, Md., June 23 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: spex ), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnolo...Spherix Announces Full-Scale Production of Pharmaceutical Tagatose
...mplete Current Phase 3 Trial of Naturlose(R) for Type 2 Diabetes BETHESDA, Md., June 23 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: spex ), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnolo...Spherix Regains Full NASDAQ Compliance
... BETHESDA, Md., May 22 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: spex ), an innovator in biotechnology for diabetes therapy and a provider of technical and regulatory consulting services to food, supplement, biotechnolog...Spherix to Exhibit at the BIO 2009 International Convention
... BETHESDA, Md., May 14 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: spex ), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnolo...Spherix Recruiting New 'Independent' Director to Regain NASDAQ Compliance
... BETHESDA, Md., April 27 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: spex ), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnolo...Spherix Incorporated Announces the Death of A. Paul Cox, Jr., Chairman of the Board
... BETHESDA, Md., April 17 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: spex ), an innovator in biotechnology and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical ...Spherix Announces 2008 Financial Results
... BETHESDA, Md., March 30 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: spex ), an innovator in biotechnology and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical ...Spherix Reports 3rd Quarter Earnings
... BETHESDA, Md., Nov. 13 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: spex ) reported a net loss for the three and nine months ended September 30, 2008 of $1.7 million ($0.12 per share) and $4.8 million ($0.34 per share), res...